Mohamed Elrishi

  • Citations Per Year
Learn More
OBJECTIVE To compare recent U.S. and U.K. guidelines on gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS The guidelines from the American Diabetes Association, the American College of Obstetricians and Gynecologists, and the National Institute for Health and Clinical Excellence (NICE) in the U.K. were collated and compared using a general(More)
In an age of increasing patient empowerment, the diagnosis of gestational diabetes mellitus (GDM) provides a woman with the knowledge that her baby has an increased chance of complications before, during, and after birth (including an increased chance of obesity and/or diabetes in the future); that she herself has an increased chance of future diabetes; and(More)
BACKGROUND Insulin glargine (Lantus) was the first recombinant-DNA long-acting insulin analogue to be licensed for use in the treatment of diabetes mellitus. OBJECTIVE This review considers the use of insulin glargine in the treatment of type 2 diabetes (T2DM). METHODS Medline, Cochrane and Embase databases were searched for relevant papers from the(More)
  • 1